Release of immunoreactive substance P in the brain stem upon stimulation of the cranial dura mater with low pH – inhibition by the serotonin (5‐HT1) receptor agonist CP 93,129
Authors:
- 1 December 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 125 (8) , 1726-1732
Abstract
1. The therapeutical benefit of serotonin (5-HT1) receptor agonists in the treatment of migraine headache has been attributed to their inhibitory effect on the release of pro-inflammatory neuropeptides from trigeminal afferents within the cranial meninges. The effect of 5-HT1 receptor agonists on the release of neuropeptides from central afferent terminals has not been examined so far. In the present study in the rat we therefore measured the effect of the 5-HT1B receptor agonist CP 93,129 on the stimulation-evoked release of immunoreactive substance P (ir-SP) in the spinal trigeminal nucleus. 2. To measure release of ir-SP, microprobes coated with antibody to substance P were inserted into the medulla oblongata at the level of the obex. The ipsilateral parietal dura mater encephali was exposed and stimulated with acid phosphate buffered Tyrode solution (pH 5.8). This chemical stimulus increased the release of ir-SP in the medullary dorsal horn. 3. Systemic (i.v.) administration of CP 93,129 (460 nmol kg(-1)) prior to stimulation suppressed the stimulation-evoked increase of release of ir-SP. Local administration of CP 93,129 (10 microM) to the dorsal surface of the medulla had no significant inhibitory effect on the release. 4. It is concluded that systemically applied 5-HT1 receptor agonists reduce the stimulation-evoked release of substance P from the central endings of meningeal afferents in the spinal trigeminal nucleus (medullary dorsal horn). This inhibitory effect may contribute to the antinociceptive effect of 5-HT1 receptor agonists in migraine.Keywords
This publication has 49 references indexed in Scilit:
- Ineffectiveness of Neurokinin-1 Antagonist in Acute MigraineCephalalgia, 1997
- Sensitization of meningeal sensory neurons and the origin of headachesNature, 1996
- Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of ratsNeuropharmacology, 1995
- The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and catsAnnals of Neurology, 1993
- Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal gangliaEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglionNeuropharmacology, 1991
- Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistryJournal of the Autonomic Nervous System, 1989
- Localization of serotonin- and substance P-like immunofluorescence in the caudal spinal trigeminal nucleus of the ratNeuroscience Letters, 1988
- Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulationPain, 1986
- Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistryJournal of Comparative Neurology, 1984